Glenmark Pharmaceuticals gets go-ahead to conduct trials with ‘favipiravir’ on COVID-19 patients
Bangalore: Glenmark Pharmaceuticals Ltd said Thursday it will start clinical trials in India of antiviral drug ‘favipiravir’. It is being ...
Read moreDetails